{"id":61264,"date":"2025-05-15T19:02:18","date_gmt":"2025-05-15T17:02:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/"},"modified":"2025-05-15T19:02:18","modified_gmt":"2025-05-15T17:02:18","slug":"prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/","title":{"rendered":"Prenuvo Welcomes Jill Woodworth, Former Peloton CFO, As Chief Financial Officer"},"content":{"rendered":"
\n

\nWoodworth helped lead Peloton from pre-IPO to $4B+ in revenue, now she\u2019s bringing that experience to a pioneer in proactive health<\/i>\n<\/p>\n

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Prenuvo<\/a>, a leader in proactive whole-body MRI screening, today announced the appointment of Jill Woodworth as Chief Financial Officer. A seasoned financial executive with deep experience leading high-growth companies through IPO and beyond, Woodworth will lead Prenuvo\u2019s financial strategy, operations, and long-term planning as the company enters its next phase of growth.\n<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nWoodworth is best known for her role as Chief Financial Officer at Peloton, where she helped scale the company from a late-stage startup into a publicly traded business with more than $4 billion in annual revenue at the time. She played a critical role in preparing the company for its IPO, navigating pandemic-era demand surges, and building operational infrastructure to support massive consumer adoption. Prior to Peloton, she spent over two decades as a Managing Director at J.P. Morgan and as an Executive Director at Morgan Stanley, advising Fortune 500 companies in the consumer and retail sectors on IPOs, M&A, and capital strategy. She most recently served as CFO at Alation, a data intelligence platform backed by top-tier investors.\n<\/p>\n

\n\u201cWhat drew me to Prenuvo is the same thing that drew me to Peloton years ago, the opportunity to change lives at scale,\u201d said Jill Woodworth. \u201cAfter experiencing a scan myself, I realized how powerful it is to truly see what\u2019s happening inside your body. The more I learned, the clearer it became that no one else in this space is approaching this like Prenuvo. I believe Prenuvo and proactive healthcare can become as ubiquitous and essential as fitness and wellness movements have become in the past decade. I\u2019m excited to help build a future where taking control of your health is a natural, expected part of life for everyone.”\n<\/p>\n

\n\u201cJill brings a rare combination of financial acumen and a deep understanding of consumer-driven health,\u201d said Andrew Lacy, Founder and CEO of Prenuvo Inc. \u201cShe\u2019s helped build one of the most recognized brands of the last decade, and her leadership will be essential as we scale globally and continue making proactive health more accessible.\u201d\n<\/p>\n

\nPrenuvo has quickly emerged as a category leader in proactive health and is now seeing record scan volumes month over month, driven by rising demand for early health insights across a broad range of consumer patient populations. Earlier this year, the company announced a historic milestone of 100,000 scans and net profitability. Since then, Prenuvo has surpassed 130,000 scans and introduced its Enhanced Scan, which combines whole-body imaging, advanced neuro screening, and blood diagnostics. In locations where it\u2019s available, the Enhanced Scan already accounts for a quarter of business, underscoring a growing demand for a single, trusted destination where patients can get a comprehensive view of their health without the complexity of piecing together multiple tests or providers. With 15 more locations set to launch – including the company\u2019s first sites in Europe and Australia – Prenuvo is scaling quickly to meet growing demand.\n<\/p>\n

\nPrenuvo integrates MRI technology, its proprietary scanning protocols, AI tools and in-house R&D, and clinical reporting into a single, unified experience, enabling tighter quality control and a more seamless path from scan to diagnosis. The Prenuvo Medical Group brings together 150+ healthcare practitioners, including the world\u2019s largest private radiology team dedicated entirely to proactive whole body MRI screening, with over 100 board-certified radiologists on staff.\n<\/p>\n

\nAbout Prenuvo<\/b>\n<\/p>\n

\nPrenuvo makes MRI scanning for early detection of many types of cancer and many other diseases seamless and more widely accessible. Combining cutting-edge analysis technology with radiation-free and non-invasive full-body scans, Prenuvo\u2019s patient-centric design is optimized to assess the body holistically and in under 60 minutes, compared with the several hours it would take to achieve this level of insight from conventional MRI scans.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:<\/b>
Christine Alabastro
\n
media@prenuvo.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Woodworth helped lead Peloton from pre-IPO to $4B+ in revenue, now she\u2019s bringing that experience to a pioneer in proactive health REDWOOD CITY, Calif.–(BUSINESS WIRE)–Prenuvo, a leader in proactive whole-body MRI screening, today announced the appointment of Jill Woodworth as Chief Financial Officer. A seasoned financial executive with deep experience leading high-growth companies through IPO … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61264","6":"format-standard","7":"category-industry"},"yoast_head":"\nPrenuvo Welcomes Jill Woodworth, Former Peloton CFO, As Chief Financial Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prenuvo Welcomes Jill Woodworth, Former Peloton CFO, As Chief Financial Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Woodworth helped lead Peloton from pre-IPO to $4B+ in revenue, now she\u2019s bringing that experience to a pioneer in proactive health REDWOOD CITY, Calif.–(BUSINESS WIRE)–Prenuvo, a leader in proactive whole-body MRI screening, today announced the appointment of Jill Woodworth as Chief Financial Officer. A seasoned financial executive with deep experience leading high-growth companies through IPO ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-15T17:02:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250515189885\/en\/2471368\/22\/2.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Prenuvo Welcomes Jill Woodworth, Former Peloton CFO, As Chief Financial Officer\",\"datePublished\":\"2025-05-15T17:02:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\\\/\"},\"wordCount\":662,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250515189885\\\/en\\\/2471368\\\/22\\\/2.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\\\/\",\"name\":\"Prenuvo Welcomes Jill Woodworth, Former Peloton CFO, As Chief Financial Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250515189885\\\/en\\\/2471368\\\/22\\\/2.jpg\",\"datePublished\":\"2025-05-15T17:02:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250515189885\\\/en\\\/2471368\\\/22\\\/2.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250515189885\\\/en\\\/2471368\\\/22\\\/2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prenuvo Welcomes Jill Woodworth, Former Peloton CFO, As Chief Financial Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prenuvo Welcomes Jill Woodworth, Former Peloton CFO, As Chief Financial Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/","og_locale":"en_US","og_type":"article","og_title":"Prenuvo Welcomes Jill Woodworth, Former Peloton CFO, As Chief Financial Officer - Pharma Trend","og_description":"Woodworth helped lead Peloton from pre-IPO to $4B+ in revenue, now she\u2019s bringing that experience to a pioneer in proactive health REDWOOD CITY, Calif.–(BUSINESS WIRE)–Prenuvo, a leader in proactive whole-body MRI screening, today announced the appointment of Jill Woodworth as Chief Financial Officer. A seasoned financial executive with deep experience leading high-growth companies through IPO ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/","og_site_name":"Pharma Trend","article_published_time":"2025-05-15T17:02:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250515189885\/en\/2471368\/22\/2.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Prenuvo Welcomes Jill Woodworth, Former Peloton CFO, As Chief Financial Officer","datePublished":"2025-05-15T17:02:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/"},"wordCount":662,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250515189885\/en\/2471368\/22\/2.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/","url":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/","name":"Prenuvo Welcomes Jill Woodworth, Former Peloton CFO, As Chief Financial Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250515189885\/en\/2471368\/22\/2.jpg","datePublished":"2025-05-15T17:02:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250515189885\/en\/2471368\/22\/2.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250515189885\/en\/2471368\/22\/2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/prenuvo-welcomes-jill-woodworth-former-peloton-cfo-as-chief-financial-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Prenuvo Welcomes Jill Woodworth, Former Peloton CFO, As Chief Financial Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61264","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61264"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61264\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61264"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61264"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61264"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}